Silverfin false false 31/12/2025 01/01/2025 31/12/2025 Mr E Beard 02/07/2025 07/11/2019 Dr J Conner 01/09/2025 Mr A R Kelliher 01/09/2025 Mercia Fund Management (Nominees) Limited 06/07/2023 Ms S Neumann 02/07/2025 11/12/2019 Dr M Nicolson 03/04/2018 Dr P Vanlaeke 01/09/2025 27/09/2019 23 September 2026 The principal activity of the company is the research and development of medical products that improve the healthcare outcomes of patients treated using extra-corporeal therapies, such as dialysis. SC586903 2025-12-31 SC586903 bus:Director1 2025-12-31 SC586903 bus:Director2 2025-12-31 SC586903 bus:Director3 2025-12-31 SC586903 bus:Director4 2025-12-31 SC586903 bus:Director5 2025-12-31 SC586903 bus:Director6 2025-12-31 SC586903 bus:Director7 2025-12-31 SC586903 2024-12-31 SC586903 core:CurrentFinancialInstruments 2025-12-31 SC586903 core:CurrentFinancialInstruments 2024-12-31 SC586903 core:Non-currentFinancialInstruments 2025-12-31 SC586903 core:Non-currentFinancialInstruments 2024-12-31 SC586903 core:ShareCapital 2025-12-31 SC586903 core:ShareCapital 2024-12-31 SC586903 core:SharePremium 2025-12-31 SC586903 core:SharePremium 2024-12-31 SC586903 core:OtherCapitalReserve 2025-12-31 SC586903 core:OtherCapitalReserve 2024-12-31 SC586903 core:RetainedEarningsAccumulatedLosses 2025-12-31 SC586903 core:RetainedEarningsAccumulatedLosses 2024-12-31 SC586903 2023-12-31 SC586903 core:OtherResidualIntangibleAssets 2024-12-31 SC586903 core:OtherResidualIntangibleAssets 2025-12-31 SC586903 core:PlantMachinery 2024-12-31 SC586903 core:OfficeEquipment 2024-12-31 SC586903 core:ComputerEquipment 2024-12-31 SC586903 core:PlantMachinery 2025-12-31 SC586903 core:OfficeEquipment 2025-12-31 SC586903 core:ComputerEquipment 2025-12-31 SC586903 bus:OrdinaryShareClass1 2025-12-31 SC586903 bus:OrdinaryShareClass2 2025-12-31 SC586903 bus:OrdinaryShareClass3 2025-12-31 SC586903 bus:OrdinaryShareClass4 2025-12-31 SC586903 bus:OrdinaryShareClass5 2025-12-31 SC586903 bus:OtherShareClass1 2025-12-31 SC586903 bus:OtherShareClass2 2025-12-31 SC586903 2025-01-01 2025-12-31 SC586903 bus:FilletedAccounts 2025-01-01 2025-12-31 SC586903 bus:SmallEntities 2025-01-01 2025-12-31 SC586903 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 SC586903 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 SC586903 bus:Director1 2025-01-01 2025-12-31 SC586903 bus:Director2 2025-01-01 2025-12-31 SC586903 bus:Director3 2025-01-01 2025-12-31 SC586903 bus:Director4 2025-01-01 2025-12-31 SC586903 bus:Director5 2025-01-01 2025-12-31 SC586903 bus:Director6 2025-01-01 2025-12-31 SC586903 bus:Director7 2025-01-01 2025-12-31 SC586903 core:OtherResidualIntangibleAssets core:TopRangeValue 2025-01-01 2025-12-31 SC586903 core:PlantMachinery core:TopRangeValue 2025-01-01 2025-12-31 SC586903 core:OfficeEquipment core:TopRangeValue 2025-01-01 2025-12-31 SC586903 core:ComputerEquipment core:TopRangeValue 2025-01-01 2025-12-31 SC586903 2024-01-01 2024-12-31 SC586903 core:OtherResidualIntangibleAssets 2025-01-01 2025-12-31 SC586903 core:PlantMachinery 2025-01-01 2025-12-31 SC586903 core:OfficeEquipment 2025-01-01 2025-12-31 SC586903 core:ComputerEquipment 2025-01-01 2025-12-31 SC586903 core:Non-currentFinancialInstruments 2025-01-01 2025-12-31 SC586903 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 SC586903 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 SC586903 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 SC586903 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 SC586903 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 SC586903 bus:OrdinaryShareClass3 2024-01-01 2024-12-31 SC586903 bus:OrdinaryShareClass4 2025-01-01 2025-12-31 SC586903 bus:OrdinaryShareClass4 2024-01-01 2024-12-31 SC586903 bus:OrdinaryShareClass5 2025-01-01 2025-12-31 SC586903 bus:OrdinaryShareClass5 2024-01-01 2024-12-31 SC586903 bus:OtherShareClass1 2025-01-01 2025-12-31 SC586903 bus:OtherShareClass1 2024-01-01 2024-12-31 SC586903 bus:OtherShareClass2 2025-01-01 2025-12-31 SC586903 bus:OtherShareClass2 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC586903 (Scotland)

INVIZIUS LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH THE REGISTRAR

INVIZIUS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025

Contents

INVIZIUS LIMITED

BALANCE SHEET

AS AT 31 DECEMBER 2025
INVIZIUS LIMITED

BALANCE SHEET (continued)

AS AT 31 DECEMBER 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 4 26 29
Tangible assets 5 217,007 404,653
217,033 404,682
Current assets
Debtors 6 312,149 298,501
Cash at bank and in hand 396,677 741,984
708,826 1,040,485
Creditors: amounts falling due within one year 7 ( 142,263) ( 281,868)
Net current assets 566,563 758,617
Total assets less current liabilities 783,596 1,163,299
Creditors: amounts falling due after more than one year 8 ( 53,568) ( 85,189)
Net assets 730,028 1,078,110
Capital and reserves
Called-up share capital 9 2,178 1,479
Share premium account 13,817,799 12,724,248
Other reserves ( 22 ) ( 22 )
Profit and loss account ( 13,089,927 ) ( 11,647,595 )
Total shareholders' funds 730,028 1,078,110

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Invizius Limited (registered number: SC586903) were approved and authorised for issue by the Board of Directors on 23 September 2026. They were signed on its behalf by:

Dr M Nicolson
Director
INVIZIUS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
INVIZIUS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Invizius Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is Suite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh, EH4 2HS, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Company's projected cash flow requirements and future funding needs. The Company will require additional cash inflows from the successful progression of commercial opportunities and/or additional funding within 12 months from the date of approval of these financial statements in order to continue its operations. The Company has significantly reduced its ongoing cost base whilst it continues to pursue commercial opportunities in relation to its technology and intellectual property. Based on the directors' current cash flow forecasts, the Company has sufficient liquidity to meet its anticipated obligations to the end of March 2027. The directors continue to actively manage expenditure and available cash resources in order to preserve liquidity and maximise the period available to progress these opportunities.

While the directors consider it appropriate to prepare the financial statements on the going concern basis, these circumstances indicate the existence of a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern. The financial statements do not include any adjustments that would result if the Company were unable to continue as a going concern.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Employee benefits

Short term benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Share-based payment

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using an appropriate model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 14 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 5 years straight line
Office equipment 4 years straight line
Computer equipment 4 years straight line
Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price including transaction costs. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, are classified as debt, are recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Government grants

Government grants are recognised based on the performance model and are measured at the fair value of the asset received or receivable when there is reasonable assurance that the Company will comply with conditions attaching to them and the grants will be received.

A grant that specifies performance conditions is recognised in income only when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the grant proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 7 13

3. Share-based payments

Equity-settled share-based payment schemes

The Company has a share option scheme for all employees and management.

Options are exercisable at a price equal to the estimated fair value of the Company’s shares on the date of grant. The options are settled by the issue of equity shares in the company and are subject to vesting conditions specified in the relevant option agreements and may lapse on cessation of employment.

Details of the share options outstanding during the financial year are as follows:

2025 2024
Weighted Average Weighted Average
Number of share options Average exercise price (£) Number of share options Average exercise price (£)
Outstanding at beginning of period 112,608 5.53000 134,981 5.92000
Granted during the period 607,501 0.00469 33,199 3.38000
Forfeited during the period ( 15,243) ( 5.01000) ( 55,572) 5.12000
Exercised during the period ( 607,501) 0.00469 0 0
Outstanding at the end of the period 97,365 5.62000 112,608 5.53000
Exercisable at the end of the period 0 0 0 0

The fair value of the share options at the grant date was calculated using the Black Scholes model, which is considered to be the most appropriate generally accepted valuation method of measuring fair value. No share-based payment expense has been recognised in the year (2024: £nil).

4. Intangible assets

Other intangible assets Total
£ £
Cost
At 01 January 2025 50 50
At 31 December 2025 50 50
Accumulated amortisation
At 01 January 2025 21 21
Charge for the financial year 3 3
At 31 December 2025 24 24
Net book value
At 31 December 2025 26 26
At 31 December 2024 29 29

5. Tangible assets

Plant and machinery Office equipment Computer equipment Total
£ £ £ £
Cost
At 01 January 2025 990,245 8,740 25,061 1,024,046
Additions 0 0 2,225 2,225
Disposals ( 54,171) ( 7,317) 0 ( 61,488)
At 31 December 2025 936,074 1,423 27,286 964,783
Accumulated depreciation
At 01 January 2025 597,166 4,959 17,268 619,393
Charge for the financial year 181,881 1,795 4,318 187,994
Disposals ( 53,797) ( 5,814) 0 ( 59,611)
At 31 December 2025 725,250 940 21,586 747,776
Net book value
At 31 December 2025 210,824 483 5,700 217,007
At 31 December 2024 393,079 3,781 7,793 404,653

6. Debtors

2025 2024
£ £
Prepayments and accrued income 64,554 43,769
VAT recoverable 22,291 16,489
Corporation tax 217,191 217,191
Other debtors 8,113 21,052
312,149 298,501

7. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 56,989 63,457
Other taxation and social security 4,541 20,062
Obligations under finance leases and hire purchase contracts (secured) 31,620 27,415
Other creditors 49,113 170,934
142,263 281,868

Net obligations under hire purchase contracts amount to £31,620 (2024 - £27,415) and are included in other creditors. These are secured over the assets to which the agreements relate.

8. Creditors: amounts falling due after more than one year

2025 2024
£ £
Obligations under finance leases and hire purchase contracts (secured) 53,568 85,189

Net obligations under hire purchase contracts amount to £53,568 (2024 - £85,189) and are included in other creditors. These are secured over the assets to which the agreements relate.

9. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
335,013 A Ordinary shares of £ 0.001 each (2024: 395,980 shares of £ 0.001 each) 335.01 395.98
717,222 B Ordinary shares of £ 0.001 each (2024: 880,032 shares of £ 0.001 each) 717.22 880.03
52,500 Ordinary shares of £ 0.001 each (2024: 202,500 shares of £ 0.001 each) 52.50 202.50
80,425 C1 Ordinary shares of £ 0.001 each (2024: nil shares) 80.43 0
10,725 C2 Ordinary shares of £ 0.001 each (2024: nil shares) 10.73 0
975 C3 Ordinary shares of £ 0.001 each (2024: nil shares) 0.98 0
981,278 D Ordinary shares of £ 0.001 each (2024: nil shares) 981.28 0
2,178.15 1,478.51

10. Financial commitments

Commitments

2025 2024
£ £
Total future minimum lease payments under non-cancellable operating leases 53,574 83,575